CG Oncology, Inc. Common stock (CGON) Stock Price History
Historical prices from 2024 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
CGON Stock Price Trajectory (2024–2026)
As of March 2, 2026, CG Oncology, Inc. Common stock (CGON) trades at $58.80, representing a +127.4% return over the past year. The stock has delivered a +9.6% return over five years, reflecting significant long-term value creation.
The stock reached its all-time high of $60.00 on February 25, 2026. From this peak, CGON has corrected -2.0%, currently trading 58% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers RVMD (+150.4% 1Y), INCY (+37.8% 1Y), and GMAB (+29.8% 1Y), CGON has underperformed the peer group average. Compare CGON vs RVMD →
Historical Price Data
Showing 30 of 526 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 55.79 | 59.77 | 55.79 | 58.80 | 58 | +4.79% |
| 2026-02-26 | 57.03 | 58.41 | 55.18 | 56.11 | 56 | -1.54% |
| 2026-02-25 | 59.44 | 60.00 | 56.64 | 56.99 | 56 | -2.31% |
| 2026-02-24 | 58.30 | 59.08 | 57.74 | 58.34 | 58 | +0.05% |
| 2026-02-23 | 57.06 | 59.95 | 55.08 | 58.31 | 58 | +1.18% |
| 2026-02-20 | 55.85 | 58.25 | 55.00 | 57.63 | 57 | +2.14% |
| 2026-02-19 | 54.43 | 56.85 | 54.24 | 56.42 | 638K | +2.19% |
| 2026-02-18 | 53.67 | 55.84 | 53.60 | 55.21 | 821K | +7.14% |
| 2026-02-17 | 50.85 | 51.99 | 50.85 | 51.53 | 18K | +0.06% |
| 2026-02-13 | 51.66 | 52.77 | 50.58 | 51.50 | 735K | -0.23% |
| 2026-02-12 | 53.83 | 53.95 | 51.58 | 51.62 | 802K | -3.60% |
| 2026-02-11 | 52.65 | 53.76 | 51.50 | 53.55 | 456K | +0.87% |
| 2026-02-10 | 51.37 | 53.88 | 51.23 | 53.09 | 1.14M | +3.94% |
| 2026-02-09 | 50.09 | 51.15 | 49.25 | 51.08 | 757K | +1.43% |
| 2026-02-06 | 50.93 | 51.50 | 49.71 | 50.36 | 842K | +2.36% |
| 2026-02-05 | 51.71 | 52.19 | 48.51 | 49.20 | 1.08M | -5.35% |
| 2026-02-04 | 52.49 | 52.99 | 50.94 | 51.98 | 819K | -1.10% |
| 2026-02-03 | 54.47 | 55.64 | 51.38 | 52.56 | 1.31M | -3.28% |
| 2026-02-02 | 51.67 | 54.63 | 51.67 | 54.34 | 640K | +4.40% |
| 2026-01-30 | 53.23 | 54.00 | 51.40 | 52.05 | 778K | -2.56% |
| 2026-01-29 | 53.85 | 54.86 | 53.00 | 53.42 | 701K | -0.78% |
| 2026-01-28 | 54.90 | 55.81 | 53.51 | 53.84 | 659K | -2.29% |
| 2026-01-27 | 53.20 | 55.12 | 52.95 | 55.10 | 882K | +3.38% |
| 2026-01-26 | 53.00 | 53.69 | 51.93 | 53.30 | 672K | -0.95% |
| 2026-01-24 | 54.76 | 55.44 | 53.33 | 53.81 | 1.49M | 0.00% |
| 2026-01-23 | 54.76 | 55.44 | 53.33 | 53.81 | 1.81M | -3.65% |
| 2026-01-22 | 57.30 | 57.39 | 54.73 | 55.85 | 2.83M | -2.24% |
| 2026-01-21 | 55.03 | 57.88 | 53.89 | 57.13 | 2.89M | +4.46% |
| 2026-01-20 | 53.11 | 55.53 | 52.51 | 54.69 | 922K | -0.07% |
| 2026-01-16 | 53.20 | 55.17 | 52.17 | 54.73 | 1.05M | +3.13% |
See CGON's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CGON Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare CGON vs AGIO
See how CGON stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has CGON stock performed recently?
CGON returned +127.4% over the past year, beating its 5-year annualized CAGR of +9.6%. The stock trades above its 200-day moving average, confirming the uptrend.
What is CGON's all-time high price?
CG Oncology, Inc. Common stock reached $60.00 on 2026-02-25. The 52-week high is $60.00. Current 1-year return of +127.4% places the stock closer to historical peaks.
Where can I download CGON historical price data?
This page provides CGON daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2024-2026, downloadable in CSV format.